Research Overview: Halotestin 5mg Swiss Healthcare
Halotestin 5mg by Swiss Healthcare is a synthetic anabolic-androgenic steroid compound that represents one of the most potent oral androgens available for laboratory investigation. This research chemical, containing fluoxymesterone as its active constituent, demonstrates exceptional binding affinity to androgen receptors, making it a valuable subject for in-vitro studies examining steroid-receptor interactions and cellular response mechanisms. Researchers at Stroid UK Shop frequently utilise this compound to investigate the molecular pathways involved in androgenic signalling and protein synthesis modulation. The compound’s unique 11β-hydroxy substitution provides distinct pharmacological characteristics that differentiate it from other anabolic steroids, offering researchers opportunities to study specific androgenic mechanisms without significant estrogenic interference. Laboratory studies have examined its potent androgenic properties, which exceed those of testosterone by significant margins, making it particularly useful for comparative steroid receptor research.
Laboratory Research Applications
Scientific investigations into Halotestin 5mg focus primarily on its extraordinary androgenic potency and minimal aromatisation properties. Research teams examine its interaction with androgen receptors to understand how structural modifications affect binding affinity and transcriptional activity. The compound serves as an excellent model for studying non-aromatising androgens, as it demonstrates negligible conversion to estrogenic metabolites under laboratory conditions. Comparative studies often utilise this compound alongside other research chemicals from our Halotestin collection to evaluate relative receptor binding characteristics. Cellular biology research examines its effects on protein synthesis pathways and gene expression profiles in muscle tissue samples. Additionally, metabolic studies investigate the compound’s influence on gluconeogenesis and hepatic enzyme systems. Researchers studying steroid metabolism frequently analyse its biotransformation pathways and metabolite formation patterns. The compound’s resistance to 5α-reductase enzyme activity makes it valuable for investigating selective androgenic mechanisms, while its oral bioavailability characteristics provide insights into steroid absorption and first-pass metabolism effects in controlled laboratory environments.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Fluoxymesterone |
| Concentration | 5mg per tablet |
| Manufacturer | Swiss Healthcare |
| Form | Oral tablets |
| CAS Number | 76-43-7 |
| Molecular Formula | C20H29FO3 |
| Molecular Weight | 336.44 g/mol |
| Storage | Room temperature, dry conditions |
This research compound complements other investigational materials available through our SARMs and peptides categories for comprehensive comparative studies.
Research Compliance Statement
This product is intended strictly for laboratory research purposes only. Not approved for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must comply with institutional guidelines and local regulations governing research chemical handling and storage protocols.
